|4.||Dysmenorrhea (Menstrual Pain)
|1.||Schaeffer, Anthony J: 20 articles (01/2015 - 08/2002)|
|2.||Nickel, J Curtis: 19 articles (07/2015 - 08/2002)|
|3.||Landis, J Richard: 10 articles (07/2015 - 08/2002)|
|4.||Check, J H: 10 articles (01/2015 - 01/2005)|
|5.||Rudick, Charles N: 10 articles (01/2014 - 09/2007)|
|6.||Krieger, John N: 10 articles (11/2012 - 06/2002)|
|7.||Khan, Khalid S: 9 articles (01/2016 - 01/2006)|
|8.||Berger, Richard E: 9 articles (04/2011 - 08/2004)|
|9.||Parsons, C Lowell: 9 articles (02/2011 - 09/2002)|
|10.||Vercellini, Paolo: 8 articles (12/2015 - 01/2002)|
|1.||3- (2- carboxypiperazin- 4- yl)propyl- 1- phosphonic acid (CPP)IBA
01/01/2010 - "To assess the efficacy of intravaginal electrical stimulation (IVES) or placebo in women with chronic pelvic pain (CPP) with no apparent cause. "
01/01/2010 - "These guidelines were prepared on behalf of the European Association of Urology (EAU) to help urologists assess the evidence-based management of chronic pelvic pain (CPP) and to incorporate the recommendations into their clinical practice. "
04/01/2006 - "To describe the attitudes that women with chronic pelvic pain (CPP) attending gynaecology clinics have to their consultations and to determine the ways in which their health care can be improved. "
04/01/2005 - "To evaluate the efficacy of intravaginal electrical stimulation in women with chronic pelvic pain (CPP). "
09/01/2001 - "To review the role of laparoscopy in the management of chronic pelvic pain (CPP). "
|2.||Gonadotropin-Releasing Hormone (GnRH)FDA Link
11/01/2009 - "To assess the safety and efficacy of long-term use of long-acting GnRH agonist in women with chronic cyclical pelvic pain using immediate versus delayed add-back hormonal replacement therapy (HRT). "
11/01/2009 - "Long-term use of GnRH agonist plus immediate add-back HRT is a safe and acceptable approach to intractable cyclical pelvic pain. "
11/01/2009 - "Immediate and delayed add-back hormonal replacement therapy during ultra long GnRH agonist treatment of chronic cyclical pelvic pain."
06/01/2008 - "Results demonstrated that each of these three therapies is a practical and efficient treatment regimen to maintain the relief of pelvic pain achieved by GnRH-a therapy, at least for a period of 12 months."
05/01/1999 - "Chronic pelvic pain: presumptive diagnosis and therapy using GnRH agonists."
09/01/2015 - "The extended therapy with dienogest 2 mg/day also showed an improvement in pelvic pain after 24-52 weeks (-22.5 ± 32.1 and -28.4 ± 29.9 mm, respectively) with tolerable side effects. "
01/01/2012 - "A significant decrease in pelvic pain was shown during continued dienogest treatment (P < 0.001). "
11/12/2010 - "In randomized clinical trials, oral dienogest was significantly more effective than placebo in reducing pelvic pain in patients with confirmed endometriosis. "
01/01/2012 - "Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment."
08/01/2010 - "Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study."
|4.||Leuprolide (Lupron)FDA LinkGeneric
01/01/2004 - "We carried out a longitudinal, interventional pilot study, examining the effect of leuprorelin acetate 3.75 mg (Prostap SR, Wyeth) on pelvic pain prospectively. "
01/01/1992 - "Scoring the final objective changes in the two patient groups revealed no significant difference, however the women treated with leuprorelin acetate depot registered significantly better control of pelvic pain. "
01/01/1999 - "Depot leuprolide was effective and safe for treating patients with chronic pelvic pain and clinically suspected endometriosis, confirming the potential of its empiric use in these patients."
01/01/1999 - "To evaluate and compare the safety and efficacy of leuprolide versus placebo in managing chronic pelvic pain in women with clinically suspected endometriosis. "
07/01/2006 - "Treatment with leuprolide acetate and hormonal add-back for up to 10 years in stage IV endometriosis patients with chronic pelvic pain."
|5.||Levonorgestrel (Plan B)FDA LinkGeneric
10/01/2010 - "The following is a report of a patient who experienced symphysiolysis-like pelvic pain following the use of a levonorgestrel-releasing intrauterine system."
01/01/2010 - "Local treatment with the levonorgestrel-releasing intrauterine system is an option for long-term suppression of pelvic pain."
11/01/2008 - "Is there a role for use of levonorgestrel intrauterine system in women with chronic pelvic pain?"
03/01/2012 - "At 12 months, the levonorgestrel-releasing intrauterine system group had a significantly lower median value of dysmenorrhea and noncyclic pelvic pain score. "
03/01/2012 - "To estimate the effectiveness of a postoperative levonorgestrel-releasing intrauterine system for relieving pelvic pain in patients with endometriosis. "
|6.||Danazol (Azol)FDA LinkGeneric
09/01/1991 - "Personal experience in cases in which the clinical picture (big uterus, menometrorrhagia, pelvic pain) presents a pathology of the venous vascular system, can report considerable benefit first and disappearance later of the symptomatology, with treatment using danazol at a dose of 200-300-400 mg/die. "
12/01/1987 - "In relation to placebo, danazol and high-dose MPA treatments, which did not differ from each other in efficacy, significantly alleviated pelvic pain. "
12/01/2011 - "Vaginal danazol for the treatment of endometriosis-related pelvic pain."
01/01/2007 - "Danazol for pelvic pain associated with endometriosis."
07/01/2004 - "These results show that a danazol-loaded IUD is an effective conservative therapy for patients with endometriosis-related pelvic pain."
|7.||Finasteride (Propecia)FDA LinkGeneric
03/01/1999 - "To investigate whether treatment of inflammatory chronic pelvic pain syndrome (ICPPS) with finasteride has any influence on symptoms associated with ICPPS. "
03/01/1999 - "Effects of finasteride in patients with inflammatory chronic pelvic pain syndrome: a double-blind, placebo-controlled, pilot study."
03/01/2005 - "A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis)."
05/01/2004 - "A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis)."
01/01/2004 - "This study was designed to assess the safety and efficacy of saw palmetto or finasteride in men with category III prostatitis/chronic pelvic pain syndrome (CP/CPPS). "
|8.||Goserelin (Zoladex)FDA Link
01/01/2014 - "Head-to-head comparisons of medical treatments Head-to-head comparisons showed that women taking goserelin had greater improvement in pelvic pain score (MD 3, 95% CI 2.08 to 3.92, one study, n = 47, moderate-quality evidence) at one year than those taking progestogen. "
01/01/1996 - "Zoladex-treated patients had a significantly (p = 0.016) shorter hospital stay and pelvic pain and abdominal pressure symptoms were significantly (p < 0.0001) reduced in this group. "
07/01/1993 - "To evaluate the efficacy of goserelin versus a low-dose cyclic oral contraceptive (OC) in improving pelvic pain in women with endometriosis and to compare recurrence of symptoms during follow-up. "
01/01/2006 - "All patients are being examined monthly after every Zoladex application (for subjective complaints--dysmenorrheal, dyspareunea, pelvic pain; serum estradyol-E2; amenorrhea; side effects) and every 24 months (recuperation of the menstrual cycle, pregnancy). "
02/01/1996 - "Goserelin was associated with resolution of pelvic pain in the six women who obtained relief of pain with oophorectomy. "
07/01/2005 - "The current approach to treatment of chronic pelvic pain in Italy involves first-line treatment with oral contraceptives or nonsteroidal antiinflammatory drugs. "
04/01/2000 - "Two different groups of women, 23 healthy young adults and 13 women with chronic posterior pelvic pain, were studied before and during use of oral contraceptives (OC). "
12/01/1997 - "Chronic pelvic pain: oral contraceptives and non-steroidal anti-inflammatory compounds."
08/01/1996 - "67 adolescent girls who had not responded to analgesia or oral contraceptives for pelvic pain. "
02/01/2008 - "Endometriosis is the most common cause of chronic pelvic pain in adolescent girls (50-70%), unresponsive to treatment of oral contraceptives and non-steroidal anti-inflammatory drugs. "
|10.||Dextroamphetamine (Dexedrine)FDA LinkGeneric
01/01/2015 - "Dextroamphetamine sulfate 15-mg extended release capsules were given to women with a variety of treatment refractory conditions including, but not limited to, pelvic pain. "
01/01/2007 - "Based on previous experience of dramatic relief of chronic pelvic pain of bladder origin with sympathomimetic amine therapy she was started on dextroamphetamine sulfate. "
01/01/2007 - "Dextroamphetamine sulfate was prescribed to a woman with unexplained chronic pelvic pain. "
01/01/2015 - "To determine if treatment with dextroamphetamine sulfate can reduce pelvic pain that was attributed to adenomyosis. "
01/01/2015 - "Resolution of pelvic pain related to adenomyosis following treatment with dextroamphetamine sulfate."
07/01/2004 - "Both procedures substantially improved symptoms for most patients, with an advantage for hysterectomy at 12 months for pelvic pain. "
04/01/1990 - "Patients were followed after hysterectomy for an average of 21.6 months (range 15-64), with 77 of 99 (77.8%) showing significant improvement and 22 (22.2%) having persistent pelvic pain. "
03/01/2006 - "In this study,however, a greater proportion of patients who underwent hysterectomy had improved pelvic pain scores. "
07/01/2004 - "At 12 months, a larger proportion of the patients who had undergone hysterectomy experienced improved pelvic pain (P=.021). "
07/01/2001 - "After hysterectomy, however, pelvic pain and sleeping disturbances were alleviated, and the state of energy and urinary function were improved (p < 0.00). "
03/01/1998 - "As an alternative to laparotomy, laparoscopic resection of a rudimentary horn in patients with MRKH syndrome is both feasible and beneficial in the treatment of pelvic pain."
08/01/2010 - "Robotic surgery for radical parametrectomy seems safe and feasible and may be the preferred approach in terms of both lower complication rates, and shorter hospital stay compared to laparotomy, with the same results in terms of improvement of symptoms of chronic pelvic pain, although further studies are needed to confirm this observation."
03/01/2012 - "Women undergoing laparotomy for pelvic pain from whom normal peritoneum and adhesions were excised to create primary cultures of normal peritoneal and adhesion fibroblasts. "
08/01/2008 - "A group of 41 women with chronic pelvic pain of more than 6 months' duration and scheduled to undergo laparoscopy or laparotomy were surveyed to obtain information on their sexual activity. "
08/01/2008 - "Sexual behavior and findings on laparoscopy or laparotomy in women with severe chronic pelvic pain."
03/01/2012 - "Use of caudal epidural steroid injections proved beneficial in the treatment of pelvic pain symptomatology and so may be considered as an option in patients with identified sacral TC."
06/01/2015 - "Our aim was to determine the effects of pelvic floor physical therapy (PT) and levator-directed trigger-point injections (LTPI) on sexual function and levator-related pelvic pain. "
09/01/2011 - "The highest and the longest effect in patients with chronic pelvic pain syndrome in combination with bladder emptying dysfunction was achieved after injections of 100 units of botulinic toxin type A into the cross-striated sphincter of the urethra."
01/01/2007 - "Levator ani trigger point injections: An underutilized treatment for chronic pelvic pain."
12/01/1993 - "Use of trigger point injections in chronic pelvic pain."
07/01/2015 - "Pelvic pain decreased significantly in both groups after treatment, with pretreatment and posttreatment scores of 7.6 ± 0.15 and 2.2 ± 0.88, respectively, in group 1 (p < 0.0001) and 7.7 ± 0.24 and 4.7 ± 0.11, respectively, in group 2 (p < 0.0001). "
01/01/2005 - "Patients' symptoms and signs including pelvic pain, pelvic tenderness, menstrual and weight changes were recorded before and after treatment. "
07/01/1993 - " In the other patients, pelvic pain returned to baseline levels 6 months after treatment ended. "
07/01/2005 - "Dysmenorrhea, noncyclic pelvic pain and pressure-like symptoms were relieved quickly and remarkably in both groups after treatment. "
09/10/2003 - "94.1% of women had improvement in menorrhagia or dysmenorrhoea, and 91.6% had improvement in bulk-related symptoms or pelvic pain six months after treatment. "
|5.||Intrauterine Devices (Intrauterine Device)
06/01/2008 - "The purpose of this report is to describe the case of a 40-year-old patient with an intrauterine device who presented abdomino-pelvic pain associated with guarding in the right iliac fossa. "
09/01/2006 - "Recent-onset chronic pelvic pain thought to originate from an intraomental Dalkon Shield intrauterine device (IUD) (A. "
09/01/2006 - "Pelvic pain associated with an unsuspected intraomental intrauterine device placed 30 years earlier: a case report."
03/01/2006 - "A 29-year-old woman in whom an intrauterine device had been placed 6 years previously, presented complaining of chronic pelvic pain and recurrent irritative urinary tract symptoms. "
02/01/1989 - "The authors describe two women with pelvic pain, long-term use of an intrauterine device, and a pelvic mass due to Actinomyces israelii. "